BIO R&D to Revenue
Bio-Rad Laboratories, Inc. Class A Common Stock · R&D to Revenue
BIO R&D to Revenue
Latest reported9.95%period ending
BIO FY R&D/Revenue (0.00% → 9.95%)
Latest values, visible window
High-resolution chart · PNG
BIO r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 9.945% | |
| 11.5293% | |
| 9.2626% | |
| 9.1672% | |
| 8.9182% | |
| 8.5544% | |
| 8.769% | |
| 8.6981% | |
| 11.5872% | |
| 9.9539% | |
| 9.5557% | |
| 10.13% | |
| 9.8913% | |
| 10.3439% | |
| 8.9914% | |
| 8.939% | |
| 9.1683% | |
| 9.0411% | |
| 9.6188% | |
| 9.6847% | |
| 9.7464% | |
| 9.9397% | |
| 9.3952% | |
| 9.2901% | |
| 9.363% | |
| 9.3872% | |
| 9.3176% | |
| 9.3686% | |
| 10.7988% | |
| 9.4556% | |
| 8.7494% | |
| 8.4999% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |